TRIB1 and colorectal carcinoma: TRIB1 is reported to be amplified in two integratedgenomics and transcriptomic profiling studies on CRC cell lines and breast cancercell lines, whereas in the latter TRIB1 was highlighted as a potential additionalamplicon driver [41, 49].